Back to results
US 7,396,649 B2Granted
Migraine and vasodilation treatment
AssigneePhilip-John Lamey
InventorsPhilip-John Lamey, Fionnuala Teresa Lundy, Christopher Shaw
Life of this patent
Estimating the term…
Abstract
The present invention related to the use of Cystatin in predicting onset of migraines. The invention also relates to the use of Cystatin as a vasodilatory agent. The invention also relates to antagonists to Cystatin for use in treating and preventing and treating migraine attacks.
Claims5
A method of monitoring an individual to predict potential migraine attacks, the method comprising the steps of:
- establishing a level of Cystatin SN for an individual at a first time point, and then
- testing for variations of the level of Cystatin SN at a later time point,
- wherein an elevated level of Cystatin SN at the later time point relative to the level of Cystatin SN at the first time point is predictive of the onset of a migraine attack.
Dependencies are inferred from the claim text.